[Liebert] Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAFV600E-Mutated Anaplastic Thyroid Carcinoma

kleinhev Post time 2024-5-23 18:35:59 | Show all posts |Read mode
Reward10points

journal£ºThyroid(R)

Authors£ºSarah Hamidi; Priyanka C. Iyer; Ramona Dadu; Maria K. Gule-Monroe; Anastasios Maniakas; Mark E. Zafereo; Jennifer R. Wang; Naifa L. Busaidy; Maria E. Cabanillas

Published date£º2024-3-1

DOI£º10.1089/thy.2023.0573

PDF link£ºhttps://www.liebertpub.com/doi/full-xml/10.1089/thy.2023.0573

Article link£ºhttp://dx.doi.org/10.1089/thy.2023.0573

Article Source£ºMary Ann Liebert Inc¡£


Remark£º

Best Answer

Reply

Use magic Donate Report

All Reply1 Show all posts
fernandoribeiro Post time 2024-5-23 18:36:00 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    905

Latest Reply

Return to the list